57653-35-7

Basic information

• Product Name: CIS-ZHPROME
• Synonyms: CIS-ZHPROME;N-CARBOBENZYLOXY-(4S)-HYDROXY-L-PROLINE METHYL ESTER;N-CBZ-CIS-4-HYDROXY-L-PROLINE METHYL ESTER;(2S,4S)-1-Benzyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate;O1-Benzyl O2-methyl (2S,4S)-4-hydroxypyrrolidine-1,2-dicarboxylate
• CAS NO: 57653-35-7
• Molecular Formula: C₁₄H₁₇NO₅
• Molecular Weight: 279.3
• Mol File: 57653-35-7.mol
• Article Data: 16

Chemical Properties

• Melting Point: 80-85°C
• Boiling Point: 422.8±45.0 °C(Predicted)
• Appearance: /
• Density: 1.313±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 14.25±0.40(Predicted)
• CAS DataBase Reference: CIS-ZHPROME(CAS DataBase Reference)
• NIST Chemistry Reference: CIS-ZHPROME(57653-35-7)
• EPA Substance Registry System: CIS-ZHPROME(57653-35-7)

Safety Data

• Hazard Codes: Xi
• Statements: 36
• Safety Statements: 26
• WGK Germany: 2
• Hazardous Substances Data: 57653-35-7(Hazardous Substances Data)

Usage

General Description

I'm sorry, but I could not find any information pertaining to a chemical named "CIS-ZHPROME." It's possible there may be a spelling error or it could be a proprietary or less-common term that is not broadly represented in available literature. Please provide additional details or ensure the name is correctly spelled so accurate information can be given.

Upstream product

• 501-53-1 benzyl chloroformate 
• 1527519-52-3 (2S,4S)-1-benzyl 2-methyl 4-(benzoyloxy)pyrrolidine-1,2-dicarboxylate 
• 117811-78-6 methyl (2S,4R)-1-benzyloxycarbonyl-4-methanesulfonyloxypyrrolidine-2-carboxylate 
• 13504-85-3 (2S,4R)-1-(benzyloxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid 
• 51-35-4 4R-4-hydroxyproline 
• 13500-53-3 N-benzyloxycarbonyl-(2S,4R)-4-hydroxyproline benzyl ester 
• 67-56-1 methanol 
• 13504-86-4 (2S,4S)-1-benzyloxycarbonyl-4-hydroxyproline 
• 64187-48-0 methyl (2S,4R)-1-benzyloxycarbonyl-4-hydroxypyrrolidine-2-carboxylate 
• 80986-14-7 5-aza-5-carbobenzoxy-2-oxa-3-oxo-bicyclo<2.2.1>heptane 
• 16217-15-5 1-benzyloxycarbonyl-4-oxo-L-proline methyl ester 
• 186581-53-3 diazomethane 
• 189215-87-0 (2S,4S)-4-(4-Nitro-benzoyloxy)-pyrrolidine-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester 
• 618-28-0 trans-4-hydroxy-D,L-proline 

Downstream Products

• 1035596-36-1 (2S,4R)-1-benzyl 2-methyl 4-(1,3-dioxoisoindolin-2-yl)pyrrolidine-1,2-dicarboxylate 
• 279-33-4 (1S,4S)-2-oxa-5-aza-bicyclo[2.2.1]heptane 
• 16217-15-5 1-benzyloxycarbonyl-4-oxo-L-proline methyl ester 
• 16217-17-7 7-<(phenylmethoxy)carbonyl>-1,4-dioxa-7-azaspiro<4,4>-nonane-8(S)-carboxylic acid methyl ester 
• 1256390-39-2 (S)-7-((S)-2-methoxycarbonylamino-3-methyl-butyryl)-1,4-dioxa-7-aza-spiro[4.4]nonane-8-carboxylic acid 2-(4-bromo-phenyl)-2-oxo-ethyl ester 
• 1256390-26-7 methyl ((S)-1-((S)-8-(5-(4-bromophenyl)-1H-imidazol-2-yl)-1,4-dioxa-7-azaspiro[4.4]nonan-7-yl)-3-methyl-1-oxobutan-2-yl)carbamate 
• 1399843-64-1 methyl ((S)-3-methyl-1-oxo-1-((S)-8-(5-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazol-2-yl)-1,4-dioxa-7-azaspiro[4.4]nonan-7-yl)butan-2-yl)carbamate 
• 556834-89-0 1-benzyl 2-methyl (2S)-4-fluoropyrrolidine-1,2-dicarboxylate 
• 117653-45-9 (1R,5R)-4-((1R,2S)-1-Carboxy-2-methyl-butylamino)-3-cyano-6-aza-bicyclo[3.2.1]oct-3-ene-6-carboxylic acid benzyl ester 
• 117653-45-9 (1S,5S)-4-((1S,2S)-1-Carboxy-2-methyl-butylamino)-3-cyano-6-aza-bicyclo[3.2.1]oct-3-ene-6-carboxylic acid benzyl ester 
• 115545-81-8 4-(1-tert-Butoxycarbonyl-ethylamino)-3-cyano-6-aza-bicyclo[3.2.1]oct-3-ene-6-carboxylic acid benzyl ester 
• 115545-80-7 methyl N-<4-<6-(benzyloxycarbonyl)-3-cyano-6-azabicyclo<3.2.1>oct-2-enyl>>-L-alaninate 
• 115545-76-1 6-(benzyloxycarbonyl)-3-cyano-4-keto-6-azabicyclo<3.2.1>octane 
• 115545-79-4 6-(benzyloxycarbonyl)-3-cyano-4-chloro-6-azabicyclo<3.2.1>oct-3-ene 

Relevant articles and documents

ROR [gamma]t inhibitor, preparation method and application thereof

The invention relates to the technical field of medicines, in particular to an ROR [gamma]t inhibitor, a preparation method and application thereof. The invention also relates to a pharmaceutical composition containing the compound, a method for preparing the pharmaceutical composition, and application of the compound or the pharmaceutical composition in treatment or prevention of ROR [gamma]t-mediated cancers, inflammations or autoimmune diseases of mammals, especially human beings.

Five-membered heteroaromatic derivative, preparation method and application thereof

The invention belongs to the technical field of medicines, and particularly relates to a five-membered heteroaromatic compound, a composition, a preparation method and application thereof. The compound or the composition can be used as an inhibitor of a retinoid-related orphan receptor [gamma]t (ROR [gamma]t). The invention also relates to a method for preparing the compound and the composition, and application of the compound and the composition in treatment or prevention of ROR [gamma]t-mediated cancers, inflammations or autoimmune diseases of mammals, especially human beings.

SPIRO COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS

Disclosed are spiro compounds of formula (I), or stereomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof. The compounds can be used to treat hepatitis C virus (HCV) infection or hepatitis C disease. Furthermore disclosed are pharmaceutical compositions containing the compounds and the method of using the compounds or pharmaceutical compositions in the treatment of HCV infection or hepatitis C disease.